Amal Trivedi
@amal_trivedi
Professor of Health Services, Policy and Practice, Brown University; Physician, Providence VA Medical Center
ID:878622419522641920
24-06-2017 14:34:43
537 Tweets
882 Followers
506 Following
A JAMA study co-authored by Regenstrief researcher and CEO Dr. Rachel Patzer, PhD, MPH finds facilities treating poor patients penalized by CMS a payment model. regenstrief.in/49YRXec
I’m supportive of alternative payment models to incentivize high value care, but we have got to deal with the unintended consequence of penalizing safety net health systems that care for our most vulnerable populations. Kudos to Kalli Koukounas Amal Trivedi for leading this work.
.Brown University School of Public Health is thrilled to announce that later this year we'll be joined by Dr. Ateev Mehrotra who will lead Health Services, Policy & Practice Department! Learn more in Dean Ashish K. Jha, MD, MPH's announcement about this physician, scholar & expert on consumerism, price transparency and benefit design. dean.sph.brown.edu/news/2024-02-0…
MA enrollment is has grown quickly, and so has enrollment in MA among those those with ADRD.
📣Check out our latest paper (w/David Meyers Amal Trivedi) documenting these trends over time ➡️ highlighting importance of understanding the performance of MA for persons with ADRD.
The historical discriminatory housing policy called redlining is linked to disparities in kidney failure incidence, underscoring the legacy of racist policies on contemporary racial inequities in kidney health bit.ly/JASN0165
Rachel Buckle-Rashid, MD @BeccaThorsness Deidra Crews, MD, ScM, FASN, MACP
Led by Kevin H. Nguyen, PhD, it was a real pleasure 2 join Amal Trivedi @BeccaThorsness Chinyere Agbai Rachel Buckle-Rashid, MD on this work, now in pre-pub JASN_News
Structural Racism, Historical Redlining, and Incidence of Kidney Failure in US Cities, 2012-2019 journals.lww.com/jasn/Abstract/…
New work in JAMA w/ Grace Oh, David Meyers, Daeho Kim, Rajnish Mehrotra, and Amal Trivedi where we examine trends in Medicare Advantage (MA) enrollment among beneficiaries with kidney failure in the first year of the 21st Century Cures Act
ja.ma/3FpL88y
1/